Amneal Pharmaceuticals, Inc.'s (NYSE:AMRX) institutional investors lost 11% over the past week but have profited from longer-term gains

Key Insights Significantly high institutional ownership implies Amneal Pharmaceuticals' stock price is sensitive to...

Related Keywords

Gautam Patel ,Fosun International Holdings Ltd ,Company Ownership ,Vanguard Group Inc ,Amneal Pharmaceuticals ,Amneal Pharmaceuticals Inc ,Institutional Ownership Tell Us About Amneal Pharmaceuticals ,Amneal Pharmaceutical ,Fosun International Holdings ,Vanguard Group ,Private Companies ,Nstitutional Ownership ,Institutional Investors ,Nsider Ownership ,